4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy
Year: 2021
Type: article
Source: Science Translational Medicine
Authors: Ulrike B. S. Hedrich, Stephan Lauxmann, Markus Wolff, Matthis Synofzik, Thomas Bast, Adrian Binelli, José M. Serratosa, Pedro Martínez-Ulloa, Nicholas M. Allen, Mary D. King, Kathleen M. Gorman, Bruria Ben Zeev, Michal Tzadok, Lily Wong-Kisiel, Dragan Marjanovic, Guido Rubboli, Sanjay M. Sisodiya, Florian Lutz, Harshad Pannikkaveettil Ashraf, Kirsten Torge, Pu Yan, Christian Bosselmann, Niklas Schwarz, Monika Fudali, Holger Lerche
Institutions: Hertie Institute for Clinical Brain Research, University of Tübingen, Vivantes Klinikum, University Children's Hospital Tübingen, German Center for Neurodegenerative Diseases, University of Freiburg, Diakonie Kork, Hospital Pedro de Elizalde, Centre for Biomedical Network Research on Rare Diseases, Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Ollscoil na Gaillimhe – University of Galway, University College Dublin, Temple Street Children's University Hospital, Tel Aviv University, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Mayo Clinic, Filadelfia, University of Copenhagen, UCL Queen Square Institute of Neurology, University College London
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3196414892